Can sodium valproate sustained-release tablets treat epilepsy?

Valproate sodium extended-release tablets are generally effective in treating epilepsy and should be used under the guidance of a physician. If discomfort occurs, timely medical attention is recommended.

Valproate sodium extended-release tablets demonstrate good control over various types of epilepsy, including generalized seizures, partial seizures, and absence seizures. This medication is an antiepileptic drug that is generally effective for treating epilepsy. If a patient is diagnosed as suitable for treatment with valproate sodium extended-release tablets and uses the medication correctly under medical guidance, it can help reduce the frequency and intensity of epileptic seizures, thereby improving the patient's quality of life.

Valproate sodium extended-release tablets exert their pharmacological effects primarily through the central nervous system, providing antiepileptic and anticonvulsant effects. The extended-release formulation allows for gradual drug release in the body, maintaining a relatively stable blood drug concentration, thereby reducing the frequency of epileptic seizures. However, it is important to note that this medication is primarily metabolized in the liver; therefore, liver function should be closely monitored during use, especially during the initial phase of treatment.

In daily life, patients should adjust their lifestyle habits during treatment to avoid potential triggers such as excessive fatigue, mental stress, alcohol consumption, etc., to promote stable disease control.